Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), By Region (North America, Europe, APAC, ROW), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                          1.1.1. Therapy Type
                          1.1.2. Regional scope
                          1.1.3. Estimates and forecast timeline
                      1.2. Research Methodology
                      1.3. Information Procurement
                          1.3.1. Purchased database
                          1.3.2. GVR’s internal database
                          1.3.3. Secondary sources
                          1.3.4. Primary research
                          1.3.5. Details of primary research
                      1.4. Information or Data Analysis
                          1.4.1. Data analysis models
                      1.5. Market Formulation & Validation
                      1.6. Model Details
                      1.7. List of Secondary Sources
                      1.8. List of Primary Sources
                      1.9. Objectives
                          1.9.1. Objective 1
                          1.9.2. Objective 2
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Therapy type outlook
                          2.2.2. Regional outlook
                      2.3. Competitive Insights
Chapter 3. Advanced Therapy Medicinal Products Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Penetration & Growth Prospect Mapping
                      3.3. Market Dynamics
                          3.3.1. Market driver analysis
                          3.3.2. Market restraint analysis
                      3.4. Advanced Therapy Medicinal Products Market Analysis Tools
                          3.4.1. Industry Analysis – Porter’s
                              3.4.1.1. Supplier power
                              3.4.1.2. Buyer power
                              3.4.1.3. Substitution threat
                              3.4.1.4. Threat of new entrant
                              3.4.1.5. Competitive rivalry
                          3.4.2. PESTEL Analysis
                              3.4.2.1. Political landscape
                              3.4.2.2. Technological landscape
                              3.4.2.3. Economic landscape
Chapter 4. Advanced Therapy Medicinal Products: Type Estimates & Trend Analysis
                      4.1. Advanced Therapy Medicinal Products Market: Key Takeaways
                      4.2. Advanced Therapy Medicinal Products Market: Movement & Market Share Analysis, 2022 & 2030
                      4.3. Cell Therapy
                          4.3.1. Cell therapy market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.4. Gene Therapy
                          4.4.1. Gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.5. Tissue Engineered Product
                          4.5.1. Tissue engineered product market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Advanced Therapy Medicinal Product Market: Regional Estimates & Trend Analysis
                      5.1. Regional Outlook
                      5.2. Advanced Therapy Medicinal Products Market by Region: Key Marketplace Takeaway
                      5.3. North America
                          5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                           5.3.2. U.S.
                              5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.3.3. Canada
                              5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      5.4. Europe
                          5.4.1. UK
                              5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.2. Germany
                              5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.3. France
                              5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.4. Italy
                              5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.5. Spain
                              5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.6. Sweden
                              5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.7. Norway
                              5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.4.8. Denmark
                              5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      5.5. Asia Pacific
                          5.5.1. Japan
                              5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.5.2. China
                              5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.5.3. India
                              5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.5.4. Australia
                              5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.5.5. Thailand
                              5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.5.6. South Korea
                              5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      5.6. Latin America
                          5.6.1. Brazil
                              5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.6.2. Mexico
                              5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.6.3. Argentina
                              5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                      5.7. MEA
                          5.7.1. Saudi Arabia
                              5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.7.2. South Africa
                              5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.7.3. UAE
                              5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                          5.7.4. Kuwait
                              5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
                      6.1. Recent Developments & Impact Analysis, By Key Market Participants
                      6.2. Company/Competition Categorization
                          6.2.1. Spark Therapeutics, Inc.
                              6.2.1.1. Company overview
                              6.2.1.2. Financial performance
                              6.2.1.3. Product benchmarking
                              6.2.1.4. Strategic initiatives
                          6.2.2. Bluebird Bio, Inc
                              6.2.2.1. Company overview
                              6.2.2.2. Financial performance
                              6.2.2.3. Product benchmarking
                              6.2.2.4. Strategic initiatives
                          6.2.3. Novartis AG
                              6.2.3.1. Company overview
                              6.2.3.2. Financial performance
                              6.2.3.3. Product benchmarking
                              6.2.3.4. Strategic initiatives
                          6.2.4. UniQure N.V.
                              6.2.4.1. Company overview
                              6.2.4.2. Financial performance
                              6.2.4.3. Product benchmarking
                              6.2.4.4. Strategic initiatives
                          6.2.5. Celgene Corporation
                              6.2.5.1. Company overview
                              6.2.5.2. Financial performance
                              6.2.5.3. Product benchmarking
                              6.2.5.4. Strategic initiatives
                          6.2.6. Gilead Lifesciences, Inc
                              6.2.6.1. Company overview
                              6.2.6.2. Financial performance
                              6.2.6.3. Product benchmarking
                              6.2.6.4. Strategic initiatives
                          6.2.7. Kolon TissueGene, Inc
                              6.2.7.1. Company overview
                              6.2.7.2. Financial performance
                              6.2.7.3. Product benchmarking
                              6.2.7.4. Strategic initiatives
                          6.2.8. JCR Pharmaceuticals Co., Ltd.
                              6.2.8.1. Company overview
                              6.2.8.2. Financial performance
                              6.2.8.3. Product benchmarking
                              6.2.8.4. Strategic initiatives
                          6.2.9. MEDIPOST
                              6.2.9.1. Company overview
                              6.2.9.2. Financial performance
                              6.2.9.3. Product benchmarking
                              6.2.9.4. Strategic initiatives
                          6.2.10. Vericel Corporation
                              6.2.10.1. Company overview
                              6.2.10.2. Financial performance
                              6.2.10.3. Product benchmarking
                              6.2.10.4. Strategic initiatives
                          6.2.11. PHARMICELL Co., Ltd
                              6.2.11.1. Company overview
                              6.2.11.2. Financial performance
                              6.2.11.3. Product benchmarking
                              6.2.11.4. Strategic initiatives
                          6.2.12. Organogenesis Inc.
                              6.2.12.1. Company overview
                              6.2.12.2. Financial performance
                              6.2.12.3. Product benchmarking
                              6.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 3 North America advanced therapy medicinal products market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 5 Canada advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 6 Europe advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 7 Europe advanced therapy medicinal products market, by region, 2018 - 2030 (USD Million)
Table 8 Germany advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 9 UK advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 10 France advanced therapy medicinal products, by therapy type, 2018 - 2030 (USD Million)
Table 11 Italy advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 12 Spain advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 13 Sweden advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 14 Norway advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 15 Denmark advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 17 Asia Pacific advanced therapy medicinal products market, by region, 2018 - 2030 (USD Million)
Table 18 China advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 19 Japan advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 20 India advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 21 Thailand advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 22 South Korea advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 23 Latin America advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 24 Latin America advanced therapy medicinal products market, by region, 2018 - 2030 (USD Million)
Table 25 Brazil advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 26 Mexico advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 27 Argentina advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 28 Middle East and Africa advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa advanced therapy medicinal products market, by region, 2018 - 2030 (USD Million)
Table 30 South Africa advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 31 Saudi Arabia advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 32 UAE advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)
Table 33 Kuwait advanced therapy medicinal products market, by therapy type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Advanced therapy medicinal products: market outlook
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Advanced therapy medicinal products market driver impact
Fig. 14 Advanced therapy medicinal products market restraint impact
Fig. 15 Advanced therapy medicinal products market strategic initiatives analysis
Fig. 16 Advanced therapy medicinal products market: type movement analysis
Fig. 17 Advanced therapy medicinal products market: type outlook and key takeaways
Fig. 18 Cell therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Tissue engineered product market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Global Advanced therapy medicinal products market: regional movement analysis
Fig. 22 Global Advanced therapy medicinal products market: regional outlook and key takeaways
Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)